(Q42188528)

English

The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial (English)

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

0 references

author name string

Maria Frånlund

1

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Sigrid Carlsson

2

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Johan Stranne

3

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Gunnar Aus

4

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Jonas Hugosson

5

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 April 2012

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

BJU International

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

110

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

638-643

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Assessing individual risk for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

26 October 2017

Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

17 August 2018

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

17 August 2018

Lower urinary tract symptoms and risk of prostate cancer in Japanese men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

17 August 2018

Lower urinary tract symptoms (LUTS) and sexual function in both sexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

17 August 2018

Awareness of prostate cancer among the general public: findings of an independent international survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5629001

17 August 2018

Decision-Making about PSA Testing and Prostate Biopsies: A Qualitative Study Embedded in a Primary Care Randomised Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.10962.X

21 January 2018

Lower urinary tract symptoms and risk of prostate cancer: The HUNT 2 Cohort, Norway

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General practitioners' perceptions of medicolegal risk. Using case scenarios to assess the potential impact of prostate cancer screening guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatm

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What influences men's decision to have a prostate-specific antigen test? A qualitative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening: should more biopsies be taken in larger prostates?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield

1 reference

https://pubmed.ncbi.nlm.nih.gov/22540895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1464-410X.2012.10962.X

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42188528&oldid=1935687359"